Wegovy is suitable for people with a BMI of 30 or over
The semaglutide to tirzepatide dose conversion chart and tirzepatide conversion chart can help map equivalent dose levels between compounds
Lesch KP, Widerlv E, Ekman R, Laux G, Schulte HM, Pfller H, Beckmann H
The three routes to weight-loss injections in the UK Route 1: NHS specialist weight management (NICE TA1026) NICE TA1026 was published in December 2024, and the NHS England rollout for tirzepatide began on 23rd June 2025 4,6
That history creates a special U.S
According to Mounjaros data, individuals with elevated BMI and without severe metabolic complications could reap the greatest benefits